105,000 Founder Shares Proposed Sale — EVCM (NASDAQ: EVCM)

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Form 144 reporting proposed dispositions of 105,000 shares of Common stock on behalf of Matthew Feierstein. The filing lists multiple 10b5-1 sales executed earlier in 2026, including transactions of 5,000–10,000 shares on specific dates. Shares outstanding were 177,566,869 as of 04/01/2026.

Key Figures

Proposed shares to be sold: 105,000 shares Shares outstanding: 177,566,869 shares Aggregate value example: $120,304 +2 more

5 metrics

Proposed shares to be sold 105,000 shares Securities To Be Sold section

Shares outstanding 177,566,869 shares as of 04/01/2026

Aggregate value example $120,304 10,000 shares sold on 03/04/2026

Smaller sale example $60,865.00 5,000 shares sold on 03/05/2026

Filing date context 04/01/2026 cover page date / exchange listing entry

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for MATTHEW FEIERSTEIN 03/05/2026 5,000 $60,865.00"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares market

"Securities To Be Sold Common 07/06/2021 Founders Shares Issuer 105000"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	105000	1200150.00	177566869	04/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/06/2021	Founders Shares	Issuer			105000	07/06/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	03/05/2026	5000	60865.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	03/04/2026	10000	120304.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	03/03/2026	10000	113831.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	03/02/2026	10000	113397.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	02/05/2026	5000	54133.50
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	02/04/2026	10000	107988.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	02/03/2026	10000	109903.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	02/02/2026	10000	120587.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	01/07/2026	5000	60509.50
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	01/06/2026	10000	116161.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	01/05/2026	10000	116553.00
10b5-1 Sales for MATTHEW FEIERSTEIN 3601 Walnut Street, Suite 400 Denver CO 80205	Common	01/02/2026	10000	113749.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EVCM Form 144 filing disclose?

It reports proposed dispositions of 105,000 Common shares. The filing names Morgan Stanley Smith Barney LLC as filer for Matthew Feierstein and lists prior 10b5-1 sales across January–March 2026.

Who is the reporting filer on the EVCM Form 144?

The filer is Morgan Stanley Smith Barney LLC. The filing identifies the broker address at 1 New York Plaza and indicates trades executed for Matthew Feierstein under 10b5-1 plans.

How many shares outstanding does the filing show for EVCM?

Shares outstanding are 177,566,869 as of 04/01/2026. This figure appears on the filing cover and provides context for the proposed 105,000-share disposition amount.

What recent sales does the filing list for Matthew Feierstein?

Multiple 10b5-1 sales in 2026 are listed, typically 5,000–10,000 shares each. Examples include 10,000 shares on 03/04/2026 for $120,304 and 5,000 shares on 03/05/2026 for $60,865.

Are the listed transactions marked as 10b5-1 sales in the filing?

Yes — the filing specifically labels the recent transactions as 10b5-1 Sales. Each past trade entry for January–March 2026 is identified as a 10b5-1 sale for Matthew Feierstein.